Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

[From cellular pathology to cell therapy].

Radbruch A, Schulze-Koops H.

Z Rheumatol. 2015 Feb;74(1):6-7. doi: 10.1007/s00393-014-1436-6. German. No abstract available.

PMID:
25676123
2.

Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis.

Schulze-Koops H, Giacomelli R, Samborski W, Rednic S, Herold M, Yao R, Govoni M, Vastesaeger N, Weng HH.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):201-8. Epub 2015 Jan 29.

PMID:
25664404
3.

Impact of cranial and axillary/subclavian artery involvement by color duplex sonography on response to treatment in giant cell arteritis.

Czihal M, Piller A, Schroettle A, Kuhlencordt P, Bernau C, Schulze-Koops H, Hoffmann U.

J Vasc Surg. 2015 Feb 3. pii: S0741-5214(14)02325-8. doi: 10.1016/j.jvs.2014.12.045. [Epub ahead of print]

PMID:
25659455
4.

Cardiomyopathy in murine models of systemic sclerosis.

Venalis P, Kumánovics G, Schulze-Koops H, Distler A, Dees C, Zerr P, Palumbo-Zerr K, Czirják L, Mackevic Z, Lundberg IE, Distler O, Schett G, Distler JH.

Arthritis Rheumatol. 2015 Feb;67(2):508-16. doi: 10.1002/art.38942.

PMID:
25371068
5.

Comment on: induction treatment of ANCA-associated vasculitis with a single dose of rituximab.

Moog P, Schulze-Koops H, Thürmel K.

Rheumatology (Oxford). 2015 Feb;54(2):372-3. doi: 10.1093/rheumatology/keu353. Epub 2014 Sep 8. No abstract available.

PMID:
25205824
6.

Gustatory and olfactory function in patients with granulomatosis with polyangiitis (Wegener's).

Proft F, Steinbach S, Dechant C, Witt M, Reindl C, Schulz S, Vielhauer V, Hilge R, Laubender RP, Manger K, Nüsslein H, Wendler J, Schuch F, Schulze-Koops H, Grunke M.

Scand J Rheumatol. 2014;43(6):512-8. doi: 10.3109/03009742.2014.915056. Epub 2014 Sep 10.

PMID:
25204208
7.

Qualifying unmet needs and improving standards of care in psoriatic arthritis.

Helliwell P, Coates L, Chandran V, Gladman D, de Wit M, FitzGerald O, Kavanaugh A, Strand V, Mease PJ, Boehncke WH, Langley RG, Lubrano E, Maccarone M, Schulze-Koops H, Miceli-Richard C, Queiro R.

Arthritis Care Res (Hoboken). 2014 Dec;66(12):1759-66. doi: 10.1002/acr.22404. Review. No abstract available.

8.

The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis.

Mueller RB, Schiff M, Kaegi T, Finckh A, Haile SR, Schulze-Koops H, von Kempis J; Swiss Clinical Quality Management (SCQM) physicians.

Clin Rheumatol. 2015 Jan;34(1):51-9. doi: 10.1007/s10067-014-2737-5. Epub 2014 Jul 15.

PMID:
25024096
9.

Patient and physician expectations of add-on treatment with golimumab for rheumatoid arthritis: relationships between expectations and clinical and quality of life outcomes.

Dasgupta B, Combe B, Louw I, Wollenhaupt J, Zerbini CA, Beaulieu A, Schulze-Koops H, Durez P, Wolff V, Yao R, Weng HH, Govoni M, Vastesaeger N.

Arthritis Care Res (Hoboken). 2014 Dec;66(12):1799-807. doi: 10.1002/acr.22371.

PMID:
24839031
10.

Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient survey.

Witt M, Meier J, Hammitzsch A, Proft F, Schulze-Koops H, Grunke M.

Semin Arthritis Rheum. 2014 Jun;43(6):745-50. doi: 10.1016/j.semarthrit.2013.10.010. Epub 2013 Oct 29.

PMID:
24816195
11.

Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL4R gene, rs1805010.

Leipe J, Schramm MA, Prots I, Schulze-Koops H, Skapenko A.

Arthritis Rheumatol. 2014 May;66(5):1165-75. doi: 10.1002/art.38343.

PMID:
24782180
12.

Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis.

Zhou Q, Haupt S, Kreuzer JT, Hammitzsch A, Proft F, Neumann C, Leipe J, Witt M, Schulze-Koops H, Skapenko A.

Ann Rheum Dis. 2014 Feb 21. doi: 10.1136/annrheumdis-2013-204377. [Epub ahead of print]

PMID:
24562503
13.

Ultrasound of synovitis in rheumatoid arthritis: advantages of the dorsal over the palmar approach to finger joints.

Witt MN, Mueller F, Weinert P, Nigg AP, Reindl CS, Proft F, Schulze-Koops H, Grunke M.

J Rheumatol. 2014 Mar;41(3):422-8. doi: 10.3899/jrheum.131027. Epub 2014 Feb 1.

PMID:
24488415
14.

Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort.

Mueller RB, Kaegi T, Finckh A, Haile SR, Schulze-Koops H, von Kempis J; SCQM physicians.

Rheumatology (Oxford). 2014 Apr;53(4):671-7. doi: 10.1093/rheumatology/ket399. Epub 2013 Dec 17.

PMID:
24352338
15.

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID).

Witt M, Grunke M, Proft F, Baeuerle M, Aringer M, Burmester G, Chehab G, Fiehn C, Fischer-Betz R, Fleck M, Freivogel K, Haubitz M, Kötter I, Lovric S, Metzler C, Rubberth-Roth A, Schwarting A, Specker C, Tony HP, Unger L, Wassenberg S, Dörner T, Schulze-Koops H; German Registry of Autoimmune Diseases (GRAID) Investigators.

Lupus. 2013 Oct;22(11):1142-9. doi: 10.1177/0961203313503912.

PMID:
24057058
16.

German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Albrecht K, Krüger K, Wollenhaupt J, Alten R, Backhaus M, Baerwald C, Bolten W, Braun J, Burkhardt H, Burmester GR, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Kuipers J, Krause A, Lorenz HM, Manger B, Nüßlein H, Pott HG, Rubbert-Roth A, Schneider M, Specker C, Schulze-Koops H, Tony HP, Wassenberg S, Müller-Ladner U; German Society of Rheumatology.

Rheumatol Int. 2014 Jan;34(1):1-9. doi: 10.1007/s00296-013-2848-3. Epub 2013 Aug 14. Review.

PMID:
23942828
17.

Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination.

Muller RB, Maier R, Hoschler K, Zambon M, Ludewig B, Herrmann M, Schulze-Koops H, von Kempis J.

Clin Exp Rheumatol. 2013 Sep-Oct;31(5):723-30. Epub 2013 Jun 14.

PMID:
23806224
18.

Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study.

Combe B, Dasgupta B, Louw I, Pal S, Wollenhaupt J, Zerbini CA, Beaulieu AD, Schulze-Koops H, Durez P, Yao R, Vastesaeger N, Weng HH; GO-MORE Investigators.

Ann Rheum Dis. 2014 Aug;73(8):1477-86. doi: 10.1136/annrheumdis-2013-203229. Epub 2013 Jun 5.

19.

Feasibility and reproducibility of the PsAMRIS-H score for psoriatic arthritis in low-field-strength dedicated extremity magnetic resonance imaging.

Strube H, Becker-Gaab C, Saam T, Reiser M, Schewe S, Schulze-Koops H, Treitl M.

Scand J Rheumatol. 2013;42(5):379-82. doi: 10.3109/03009742.2013.783105. Epub 2013 May 28.

PMID:
23713482
20.

miR-142-3p is involved in CD25+ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant.

Zhou Q, Haupt S, Prots I, Thümmler K, Kremmer E, Lipsky PE, Schulze-Koops H, Skapenko A.

J Immunol. 2013 Jun 15;190(12):6579-88. doi: 10.4049/jimmunol.1202993. Epub 2013 May 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk